Core Laboratories NV (CLB)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Core Laboratories NV (CLB) is down 26.5% since the beginning of the year. At $12 per share, CLB is trading 42.2% below its 52-week high of $20. Investors who bought $1,000 worth of CLB shares 5 years ago would now be looking at an investment worth $282.

Core Laboratories NV (CLB) has returned -26.48% so far this year and -4.88% over the past 12 months. Over the last ten years, CLB has returned -19.93% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Sep 21, 1995, CLB's average daily return is +0.07%, while the average monthly return is +1.42%. At this rate, an investment would double in approximately 4.1 years.

Historically, 51% of months were positive and 49% were negative. The best month was Apr 2020 with a return of +89.7%, while the worst month was Mar 2020 at -61.5%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.

On a daily basis, CLB closed higher 49% of trading days. The best single day was Oct 23, 2025 with a return of +28.8%, while the worst single day was Mar 9, 2020 at -43.3%.

Core Laboratories NV has an annualized alpha of 8.06%, beta of 0.94, and R2 of 0.13 versus S&P 500 Index. Calculated based on daily prices since September 21, 1995.

• This stock participated in 142.79% of S&P 500 Index downside but only 136.33% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.13 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CLB ranks 38 for risk / return — below 38% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

Core Laboratories NV provided a 0.34% dividend yield over the last twelve months, with an annual payout of $0.04 per share. The company has been increasing its dividends for 4 consecutive years.

The table displays the monthly dividend distributions for Core Laboratories NV. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Core Laboratories NV. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Core Laboratories NV was 95.78%, occurring on Mar 17, 2020. The portfolio has not yet recovered.

The current Core Laboratories NV drawdown is 93.70%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Core Laboratories NV over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Core Laboratories NV is priced in the market compared to other companies in the Oil & Gas Equipment & Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.